Announcements Trials

Browse Landscape

Phase

Status

Completed 4 Unknown 1 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 5 Neoplasms 4 Ovarian Neoplasms 2 Motor Activity 2 Fallopian Tube Neoplasms 2 Uncertainty 1 Polyps 1 Pancreatic Neoplasms 1 Palliative Care 1 Pain 1 Obesity 1 Neoplasm Metastasis 1 Lung Neoplasms 1 Knee Tumor 1 Inflammation 1 Head and Neck Neoplasms 1 Depression 1 Critical Illness 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Brenner Tumor 1 Breast Carcinoma In Situ 1 Breast Cancer Lymphedema 1 Adenoma 1

Interventions

Cisplatin 28 Radiotherapy 19 pembrolizumab 9 Paclitaxel 9 Surveys and Questionnaires 8 Cetuximab 8 Fluorouracil 7 Docetaxel 7 Radiotherapy, Intensity-Modulated 6 Carboplatin 6 apatinib 5 Low-Level Light Therapy 5 durvalumab 4 Standard of Care 4 Magnetic Resonance Imaging 4 Gemcitabine 4 Cyclophosphamide 4 Celecoxib 4 Blood Specimen Collection 4 Tegafur 3 Radiation 3 Oncolytic Virotherapy 3 Nivolumab 3 Magnetic Resonance Spectroscopy 3 Lidocaine 3 Immunoenzyme Techniques 3 Drug Therapy 3 Chemotherapy, Adjuvant 3 Biopsy 3 toripalimab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Head and Neck Neoplasms × Methods × Clear all

NCT01716780 2012-10-30

Pain: Screen and Treat

Royal Marsden NHS Foundation Trust

Phase 3 Unknown

Head and Neck Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡